Ana-Irina Cocarta

Dr. Ana-Irina Cocarta


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
Eduard PreisEduard Preis
Eduard Preis
TAThomas Anders
Thomas Anders
JSJakub Sirc
Jakub Sirc
RHRadka Hobzová
Radka Hobzová
ACAna-Irina Cocarta
Ana-Irina Cocarta
JJJarmila Jedelská
Jarmila Jedelská

3 May 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
RHRadka Hobzová
Radka Hobzová
JSJakub Sirc
Jakub Sirc
Kusum ShresthaKusum Shrestha
Kusum Shrestha
BMBarbora Mudrova
Barbora Mudrova
ZBZuzana Bosakova
Zuzana Bosakova
ACAna-Irina Cocarta
Ana-Irina Cocarta
Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to treat with systemically delivered drugs. Well-designed carriers can provide the required drug concentration at the target site over a prolonged time, reduce the overall drug dose needed, and suppress severe side effects. Herein, nanofibrous carriers of the anticancer agent topotecan (TPT) with a multilayered structure composed of a TPT-loaded inner layer of poly(vinyl alcohol) (PVA) and outer covering layers of polyurethane (PUR) are proposed. Scanning electron microscopy showed homogeneous incorporation of TPT into the PVA nanofibers. HPLC-FLD proved the good loading efficiency of TPT (≥85%) with a content of the pharmacologically active lactone TPT of more than 97%. In vitro release experiments demonstrated that the PUR cover layers effectively reduced the initial burst release of hydrophilic TPT. In a 3-round experiment with human retinoblastoma cells (Y-79), TPT showed prolonged release from the sandwich-structured nanofibers compared with that from a PVA monolayer, with significantly enhanced cytotoxic effects as a result of an increase in the PUR layer thickness. The presented PUR-PVA/TPT-PUR nanofibers appear to be promising carriers of active TPT lactone that could be useful for local cancer therapy.